Thoracic oncology clinical trial eligibility criteria and requirements continue to increase in number and complexity

Por Garcia, Sandra, Bisen, Ajit, Yan, Jingsheng, Xie, Xian-Jin, Ramalingam, Suresh, Schiller, Joan H., Johnson, David H., Gerber, David E.
Publicado no J Thorac Oncol (2017)

Practice Patterns and Perceptions of Thoracic Oncology Providers on Tobacco Use and Cessation in Cancer Patients

Por Warren, Graham W., Marshall, James R., Cummings, K. Michael, Toll, Benjamin, Gritz, Ellen R., Hutson, Alan, Dibaj, Seyedeh, Herbst, Roy, Dresler, Carolyn
Publicado em 2013

A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial

Por Park, Elyse R., Japuntich, Sandra, Temel, Jennifer, Lanuti, Michael, Pandiscio, Jennifer, Hilgenberg, Joanna, Davies, Diane, Dresler, Carolyn, Rigotti, Nancy A.
Publicado em 2011

Phase I Study of Dose Escalation in Hypofractionated Proton Beam Therapy for Thoracic Malignancies

Por Gomez, Daniel R., Gillin, Michael, Liao, Zhongxing, Wei, Caimiao, Lin, Steven H., Swanick, Cameron, Alvarado, Tina, Komaki, Ritsuko, Cox, James D., Chang, Joe Y.
Publicado em 2013

Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus

Por Xu, Cai, Xi, Mian, Komaki, Ritsuko, Balter, Peter A., Huang, Meilin, Hobbs, Brian P., Wang, Luhua, Lin, Steven H.
Publicado no Adv Radiat Oncol (2017)

Cisplatin versus carboplatin based regimens for the treatment of patients with metastatic lung cancer. An analysis of Veterans Health Administration data

Por Santana-Davila, Rafael, Szabo, Aniko, Arce-Lara, Carlos, Williams, Christina D., Kelley, Michael J., Whittle, Jeff
Publicado no J Thorac Oncol (2014)

Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non-Small Cell Lung Cancer after Neoadjuvant Chemotherapy

Por William, William N., Pataer, Apar, Kalhor, Neda, Correa, Arlene M., Rice, David C., Wistuba, Ignacio I., Heymach, John, Lee, J. Jack, Kim, Edward S., Munden, Reginald, Gold, Kathryn A., Papadimitrakopoulou, Vassiliki, Swisher, Stephen G., Erasmus, Jeremy J.
Publicado em 2013

Thoracoscopic enucleation of a large esophageal leiomyoma using a three thoracic ports technique

Por Akaraviputh, Thawatchai, Chinswangwatanakul, Vitoon, Swangsri, Jirawat, Lohsiriwat, Varut
Publicado em 2006

Deep Vein Thrombosis in Indian Cancer Patients Undergoing Major Thoracic and Abdomino-Pelvic Surgery

Por Jakhetiya, Ashish, Shukla, Nootan Kumar, Deo, S V Suryanarayana, Garg, Pankaj Kumar, Thulkar, Sanjay
Publicado no Indian J Surg Oncol (2016)

Utility and Reproducibility of 3-Dimensional Printed Models in Pre-Operative Planning of Complex Thoracic Tumors

Por George, Elizabeth, Barile, Maria, Tang, Anji, Wiesel, Ory, Coppolino, Antonio, Giannopoulos, Andreas, Mentzer, Steven, Jaklitsch, Michael, Hunsaker, Andetta, Mitsouras, Dimitrios
Publicado no J Surg Oncol (2017)

Obesity Increases the Risk of Chest Wall Pain from Thoracic Stereotactic Body Radiation Therapy

Por Welsh, James, Thomas, Jimmy, Shah, Deep, Allen, Pamela K., Wei, Xiong, Mitchell, Kevin, Gao, Song, Balter, Peter, Komaki, Ritsuko, Chang, Joe Y
Publicado em 2010

Phase I Trial of Nanoparticle Albumin-Bound Paclitaxel in Combination with Gemcitabine in Patients with Thoracic Malignancies

Por Stinchcombe, Thomas E., Socinski, Mark A., Lee, Carrie B., Hayes, D. Neil, Moore, Dominic T., Goldberg, Richard M., Dees, E. Claire
Publicado em 2008

Positional uncertainties of cervical and upper thoracic spine in stereotactic body radiotherapy with thermoplastic mask immobilization

Por Jeon, Seung Hyuck, Kim, Jin Ho
Publicado no Radiat Oncol J (2018)

Mediastinoscopy-assisted esophagectomy for T2 middle and lower thoracic esophageal squamous cell carcinoma patients

Por Wang, Jun, Wei, Ning, Lu, Yimin, Zhang, Xiaoying, Jiang, Nanqing
Publicado no World J Surg Oncol (2018)

Phase II Study of a Non-platinum-containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab (PPB) as Initial Therapy for Patients with Advanced Lung Adenocarcinomas

Por Pietanza, Catherine M., Hellmann, Matthew D., Fiore, John J., Smith-Marrone, Stephanie, Basch, Ethan M., Schwartz, Lawrence H., Ginsberg, Michelle S., Shouery, Marwan, Newman, Samantha K., Shaw, Mary, Rogak, Lauren J., Lash, Alex, Hilden, Patrick, Kris, Mark G.
Publicado no J Thorac Oncol (2016)

CYFRA 21-1 as a prognostic and predictive marker in advanced non-small cell lung cancer in a prospective trial: CALGB 150304

Por Edelman, Martin J., Hodgson, Lydia, Rosenblatt, Paula Y., Christenson, Robert H., Vokes, Everett, Wang, Xiaofei, Kratzke, Robert
Publicado no J Thorac Oncol (2012)

Optimization of Response Classification Criteria for Patients with Malignant Pleural Mesothelioma

Por Labby, Zacariah E., Armato, Samuel G., Kindler, Hedy L., Dignam, James J., Hasani, Arman, Nowak, Anna K.
Publicado em 2012

Features of Potentially Predictive Biomarkers of Chemotherapeutic Efficacy in Small Cell Lung Cancer

Por Chiappori, Alberto A., Zheng, Zhong, Chen, Tingan, Rawal, Bhupendra, Schell, Michael J., Mullaney, Brian P., Bepler, Gerold
Publicado em 2010

Lung Volume Measurements as a Surrogate Marker for Patient Response in Malignant Pleural Mesothelioma

Por Labby, Zacariah E., Armato, Samuel G., Dignam, James J., Straus, Christopher, Kindler, Hedy L., Nowak, Anna K.
Publicado em 2013

Multi-Modality Mediastinal Staging for Lung Cancer Among Medicare Beneficiaries

Por Farjah, Farhood, Flum, David R., Ramsey, Scott D., Heagerty, Patrick J., Symons, Rebecca Gaston, Wood, Douglas E.
Publicado em 2009